Amylyx Pharmaceuticals (AMLX) Tax Rate (2022 - 2025)
Amylyx Pharmaceuticals (AMLX) posted Tax Rate of 92.2% for Q4 2025, down 44.73% on a QoQ basis from 166.81% in Q4 2024, and down 7461.0% year-over-year from 1.25% in Q4 2024.
Analysis
Amylyx Pharmaceuticals (AMLX) Tax Rate (2022 - 2025) Analysis & Trends
Amylyx Pharmaceuticals has reported Tax Rate for 4 years, with the latest figure at 92.2% in Q4 2025.
- On a quarterly basis, Tax Rate fell 7461.0% year-over-year to 92.2% in Q4 2025; TTM through Dec 2025 was 21.0%, a 0.0% change from a year earlier, with the FY2025 full-year figure at 21.0%, changed 0.0% from the prior year.
- Tax Rate was 92.2% for Q4 2025 at Amylyx Pharmaceuticals, down from 166.81% in the prior quarter.
- The five-year high for Tax Rate was 166.81% in Q4 2024, with the low at 12.12% in Q1 2023.
- Average Tax Rate over 4 years is 26.38%, with a median of 0.23% recorded in 2022.
- The sharpest annual moves came in 2024 and 2025: Tax Rate surged 13641 bps in 2024, then tumbled 7461 bps in 2025.
- Over 4 years, Tax Rate stood at 1.33% in 2022, then surged by 2390 bps to 30.4% in 2023, then surged by 449 bps to 166.81% in 2024, then plunged by 45 bps to 92.2% in 2025.
- The last three Tax Rate figures came in at 92.2% (Q4 2025), 166.81% (Q4 2024), and 0.2% (Q1 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 212.20 Bn | 198.21 Bn | 7.24 Bn | 14.20% |
| 2 | Gilead Sciences | 181.83 Bn | 178.65 Bn | 6.22 Bn | -2.36% |
| 3 | Vertex Pharmaceuticals | 132.47 Bn | 124.61 Bn | 2.84 Bn | 20.98% |
| 4 | Regeneron Pharmaceuticals | 82.56 Bn | 74.56 Bn | 3.93 Bn | 15.11% |
| 5 | Argenx Se | 61.59 Bn | 56.40 Bn | 1.37 Bn | -10.89% |
| 6 | Moderna | 54.65 Bn | 49.51 Bn | 52.00 Mn | -1.96% |
| 7 | Alnylam Pharmaceuticals | 34.13 Bn | 30.82 Bn | 992.69 Mn | 7.49% |
| 8 | Biogen | 31.42 Bn | 30.13 Bn | 1.96 Bn | 26.36% |
| 9 | Roivant Sciences | 30.21 Bn | 30.21 Bn | 1.16 Mn | 1.34% |
| 10 | Amylyx Pharmaceuticals | 3.68 Bn | 3.68 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 92.20% |
| Dec 31, 2024 | 166.81% |
| Mar 31, 2024 | -0.20% |
| Dec 31, 2023 | 30.40% |
| Sep 30, 2023 | 6.77% |
| Jun 30, 2023 | 8.05% |
| Mar 31, 2023 | -12.12% |
| Dec 31, 2022 | -1.33% |
| Sep 30, 2022 | 0.23% |
| Jun 30, 2022 | -0.37% |
| Mar 31, 2022 | -0.31% |